Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Trends and Finance
Trinity Bioscience returns to Nasdaq compliance
By
LabPulse.com staff writers
Trinity Bioscience has announced that the it has received notice from Nasdaq that it has now regained listing compliance for the market value of its shares.
November 8, 2024
Meridian Bioscience wins Lead Detect Prize
By
LabPulse.com staff writers
Meridian Bioscience took first place in the U.S. Centers for Disease Control and Prevention's Lead Detect Prize competition.
November 7, 2024
Microbiologics acquires SensID
By
LabPulse.com staff writers
U.S. biotech firm Microbiologics has acquired German DNA diagnostics manufacturer SensID.
November 7, 2024
Aignostics garners series B funding for AI-based offerings
By
LabPulse.com staff writers
Digital pathology firm Aignostics raised $34 million in series B funding, which it will use to fuel its growth in the U.S. and develop new models.
November 4, 2024
Fulgent Genetics wins $99M precision medicine contract with VA
By
Liz Carey
The new award maintains Fulgent's focus on germline testing and also funds pharmacogenetic (PGx) testing.
October 31, 2024
Central Maine Healthcare broadens digital pathology operations
By
LabPulse.com staff writers
Additionally, Spectrum Pathology hopes to replicate its new technical model with clinical labs.
October 28, 2024
ADx Neurosciences, Alamar partner on custom biomarker assays
By
LabPulse.com staff writers
ADx NeuroSciences and Alamar Biosciences will collaborate on the development of customized biomarker assays for pharmaceutical companies devising therapeutics for neurodegenerative diseases.
October 28, 2024
LabGenomics USA adds more CLIA labs to its U.S. network
By
LabPulse.com staff writers
The acquired company has an NGS cancer panel for solid tumors and plans to launch it as an LDT.
October 28, 2024
BioAffinity secures $2.7M to advance novel lung cancer diagnostic test
By
LabPulse.com staff writers
Texas-based bioAffinity Technologies has secured nearly $2.7 million at the close of a registered direct stock offering that it will use for general corporate purposes, including working capital, to advance its novel CyPath Lung test.
October 24, 2024
Mobile lab, owners to pay $135K to settle Medicare fraud case
By
LabPulse.com staff writers
A California mobile phlebotomy operation and its owners will collectively pay $135,000 to resolve alleged fraud and Anti-Kickback Statute violations.
October 23, 2024
Twist Bioscience enters deal for $15M million cash upfront
By
LabPulse.com staff writers
Synthetic biology and genomics company Twist Bioscience has entered a deal with Xoma Royalty Corporation.
October 22, 2024
GSK files mRNA technology patent lawsuits against Moderna
By
LabPulse.com staff writers
GSK filed two lawsuits against Moderna claiming that Moderna infringed on GSK's patent rights in its mRNA COVID-19 and RSV vaccines.
October 17, 2024
Page 1 of 141
Next Page